An ongoing study is testing a new kind of neuroimaging device designed to easily capture brain activity in real-time. These preliminary experiments will investigate the effects of ketamine on ...

Peering into the human brain has never been easy. For decades, neuroscientists have relied on heavy, expensive machines to measure blood flow and oxygen levels that reveal how the brain works. These ...

Your Brain On Drugs: Psychedelic therapeutics company Cybin and neuroimaging tech startup Kernel will study patients' brains while on ketamine. The U.S. Food and Drug Administration has approved a ...

At last year's SPIE Photonics West, California-based neurotech start-up Kernel revealed the system architecture of its proposed Kernel Flux optically-pumped magnetometer platform designed to record ...

Ever wondered what’s going on inside somebody’s head? Us too, and it might just be possible to see inside another person’s brain outside a laboratory setting soon. Earlier this year, US startup Kernel ...

Using Kernel’s technology, Cybin will be able to quantify brain activity in real time during psychedelic experiences. The absence of this data has been a limitation in the progression of new molecules ...

LOS ANGELES--(BUSINESS WIRE)-- Kernel, a leader in non-invasive neuroimaging, announces the publication of their study "Measuring acute effects of subanesthetic ketamine on cerebrovascular ...

- Results to be presented at PSYCH Symposium taking place in London on May 11, 2022 - LOS ANGELES & TORONTO--(BUSINESS WIRE)--Kernel, a leader in non-invasive neuroimaging, and Cybin Inc. (NEO:CYBN) ...